Showing results 4 to 8 of 8
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
MIP combination chemotherapy versus symptomatic treatment alone in inoperable non-small cell lung cancer Proceeding/Conference:Hong Kong International Cancer Congress | 1995 | 132 | ||
Mitomycin-C, ifosphamide & cisplatinum (MIP) combination chemotherapy in patients with inoperable non-small cell lung cancer (NSCLC) Proceeding/Conference:American Journal of Respiratory & Critical Care Medicine | 1999 | 84 | ||
Mitomycin-C, ifosphamide and cis-platin combination chemotherapy in patients with inoperable non-small cell lung cancer Journal:American Journal of Respiratory and Critical Care Medicine | 1999 | 118 | ||
Mitomycin-C, ifosphamide and cisplatin combination chemotherapy in advanced non-small cell carcinoma of the lung Proceeding/Conference:Asia Pacific Congress on Diseases of the Chest | 1994 | 88 | ||
1994 | 106 |